The Chemicals industry plays a fundamental role in the modern economy by transforming raw inputs into more than 70,000 products for intermediate or final consumption. As an enabling industry, it stands at the beginning of the value chains of numerous sectors, such as agriculture, food & beverages, consumer goods, construction and pharmaceuticals. It also plays a vital role in promoting human and economic development, improving food security and public health, and ensuring the sustainable use of natural resources.
Activities associated with Chemicals are manufacturing of petroleum and coal products, basic chemicals, resins, polymers and speciality chemicals, industrial gases, fertilisers, paints and coatings, adhesives, plastics and rubber products. A number of consumer goods are also included, such as pharmaceuticals, hygiene and personal care products, cleaning compounds and toiletries.
China is the world's most populous country and the largest producer and consumer of fertilisers. The country consumes more than a third of the world’s fertilisers, which is equivalent to the combined consumption of the US and India. The country ...READ MORE
In the second quarter of 2018, China’s pharmaceutical and medicine production declined by 21.1% y/y to 749,000 tonnes, while their sales volume dropped by 22.7% y/y to 753,000 tonnes. This can be linked with the more stringent environmental ...READ MORE
Demand in the Malaysian Pharmaceuticals & Healthcare sector has been growing rapidly over the last few years as Malaysians have become more affluent and demanding with their healthcare needs. The aging population has also been seeing higher ...READ MORE
China is the world’s second largest pharmaceutical market after the US and the largest producer and exporter of active pharmaceutical ingredients (APIs) globally. Since it is the world’s most populous country, with a large share of ageing ...READ MORE
In the first two months of Q4 of 2017, the sales revenue of China’s pharmaceutical manufacturing sector went down by 17.8% y/y to RMB 445bn, as a result of the government’s tightening control over drug prices and distribution costs. ...READ MORE
Turkey’s health insurance coverage reaches 98.4% of the population, according to the OECD Health Statistics 2017. The state, through the Ministry of Health (MoH), is the main provider of health services in the country, which still has very low ...READ MORE
In 2012-2017 Chile’s total health expenditure rose at a CAGR of 11.6%, driven by a solid increase of government spending on healthcare. In 2017, Chile allocated 8.1% of its GDP on healthcare, a figure that is bound to grow in the short term. ...READ MORE
Poland is the sixth-largest market in Europe (understood as EU28 plus Norway and Switzerland) for pharmaceuticals as well as for cosmetics, with respective market sales of around PLN 38.3bn in 2017 and of at least PLN 16bn in 2016 (some estimates, ...READ MORE
Expenditure on healthcare in Romania reached RON 35.2bn in 2015, according to data provided by Eurostat. Total expenditure on healthcare was equal to 4.94% of GDP in that year. The Romanian healthcare sector was characterised by the lowest per capita ...READ MORE
Total expenditure on healthcare in Hungary in 2015 reached HUF 2,460bn, up by 6.3% y/y. Government and compulsory health care financing schemes made up 67% of the expenditure, followed by private out-of-pocket spending (29%). Voluntary healthcare ...READ MORE